Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2015 10:40 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Announces Appointment of International Diabetes Expert to Scientific Advisory Board

SILVER SPRING, Md., Nov. 19, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
November 19, 2015 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Appoints International Diabetes Expert to Its Scientific Advisory Board

SILVER SPRING, Md., Nov. 19, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
November 17, 2015 09:21 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancreatic Cancer Treatment

SILVER SPRING, Md., Nov. 17, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
November 10, 2015 10:17 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Scientific Advisory Board Member Named Clinical Director of Prestigious Boston Cancer Center

SILVER SPRING, Md., Nov. 10, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
October 29, 2015 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Hosts 2nd Annual Meeting of International Diabetes Consortium Developing Novel Treatment for Diabetes

SILVER SPRING, Md., Oct. 29, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
October 23, 2015 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Management Interviewed to Discuss Key Aspects of New Pancreatic Cancer Clinical Trial Design

SILVER SPRING, Md., Oct. 23, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
October 21, 2015 09:20 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Clinical Trial Designed to Expand Standard of Care Therapy for Pancreatic Cancer

SILVER SPRING, Md., Oct. 21, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
October 19, 2015 09:48 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech to Conduct Pancreatic Cancer Clinical Trial in United States

SILVER SPRING, Md., Oct. 19, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
October 14, 2015 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Designs Clinical Trial to Meet Critical Unmet Medical Need

SILVER SPRING, Md., Oct. 14, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
October 07, 2015 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech CEO in Europe to Secure Orphan Designation With the EMA

SILVER SPRING, Md., Oct. 07, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...